Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Derm Research, LLC
189
mi
from 43215
Louisville, KY
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Derm Research, LLC
189
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Medical Development Centers, Llc
802
mi
from 43215
Baton Rouge, LA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Medical Development Centers, Llc
802
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Hamzavi Dermatology
214
mi
from 43215
Fort Gratiot, MI
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Hamzavi Dermatology
214
mi
from 43215
Fort Gratiot, MI
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Washington University, Dermatology Clinical Trials Unit
408
mi
from 43215
Saint Louis, MO
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Washington University, Dermatology Clinical Trials Unit
408
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
DermResearchCenter of New York, Inc
524
mi
from 43215
Stony Brook, NY
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
DermResearchCenter of New York, Inc
524
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
OUHSC-Dermatology
848
mi
from 43215
Oklahoma, OK
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
OUHSC-Dermatology
848
mi
from 43215
Oklahoma, OK
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Center for Clinical Studies, Texas Medical Center
995
mi
from 43215
Houston, TX
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Center for Clinical Studies, Texas Medical Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Dermatology Clinical Research Center
1138
mi
from 43215
San Antonio, TX
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Dermatology Clinical Research Center
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
624
mi
from 43215
Overland Park, KA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
624
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
656
mi
from 43215
Rogers, AZ
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
656
mi
from 43215
Rogers, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1982
mi
from 43215
Encino, CA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1982
mi
from 43215
Encino, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
2088
mi
from 43215
Fremont, CA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
2088
mi
from 43215
Fremont, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1929
mi
from 43215
Temecula, CA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1929
mi
from 43215
Temecula, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1162
mi
from 43215
Denver, CO
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
979
mi
from 43215
Miramar, FL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
979
mi
from 43215
Miramar, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
702
mi
from 43215
Saint Augustine, FL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
702
mi
from 43215
Saint Augustine, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
831
mi
from 43215
South Tampa, FL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
831
mi
from 43215
South Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
831
mi
from 43215
Tampa, FL
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
561
mi
from 43215
Savannah, GA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
561
mi
from 43215
Savannah, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1714
mi
from 43215
Boise, ID
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1714
mi
from 43215
Boise, ID
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
855
mi
from 43215
Crowley, LA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
855
mi
from 43215
Crowley, LA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
253
mi
from 43215
Bay City, MI
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
253
mi
from 43215
Bay City, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
182
mi
from 43215
Clinton Township, MI
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
182
mi
from 43215
Clinton Township, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
214
mi
from 43215
Fort Gratiot, MI
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
214
mi
from 43215
Fort Gratiot, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
465
mi
from 43215
Verona, NJ
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
465
mi
from 43215
Verona, NJ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
549
mi
from 43215
Stony Brook, NY
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
125
mi
from 43215
Sylvania, OH
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
125
mi
from 43215
Sylvania, OH
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
2029
mi
from 43215
Oswego, OR
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
2029
mi
from 43215
Oswego, OR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
614
mi
from 43215
Johnston, RI
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
614
mi
from 43215
Johnston, RI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
933
mi
from 43215
Arlington, TX
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
987
mi
from 43215
College Station, TX
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
987
mi
from 43215
College Station, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1052
mi
from 43215
Pflugerville, TX
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1052
mi
from 43215
Pflugerville, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
993
mi
from 43215
Webster, TX
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
993
mi
from 43215
Webster, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1514
mi
from 43215
Draper, UT
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1514
mi
from 43215
Draper, UT
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1517
mi
from 43215
West Jordan, UT
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1517
mi
from 43215
West Jordan, UT
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
345
mi
from 43215
Henrico, VA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
345
mi
from 43215
Henrico, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Radiant Research, Inc.
492
mi
from 43215
Birmingham, AL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Radiant Research, Inc.
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Pivotal Research Center
1652
mi
from 43215
Mesa, AZ
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Pivotal Research Center
1652
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Pivotal Research Center
1666
mi
from 43215
Peoria, AZ
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Pivotal Research Center
1666
mi
from 43215
Peoria, AZ
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Burke Pharmaceutical Research
670
mi
from 43215
Hot Springs, AR
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Burke Pharmaceutical Research
670
mi
from 43215
Hot Springs, AR
Click here to add this to my saved trials